Overview
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Rapalogix Health | Jun 2026Led | $20 MSeries A | |
Cuprum Metals | Jun 2026Participated | $19 MSeries A | |
Skyryse | Feb 2026Participated | $300 MSeries C | |
Mirador Therapeutics | Jan 2026Participated | $250 MSeries B | |
Ursa Major | Nov 2025Participated | $150 MSeries E | |
Egetis Therapeutics | Oct 2025Participated | $19 MOther Equity | |
Equillium | Aug 2025Participated | $30 MOther Equity | |
Caris Life Sciences | Apr 2025Participated | $168 MOther Equity | |
Blue Earth Therapeutics | Oct 2024Participated | $77 MSeries A | |
Formo | Sep 2024Participated | $61 MSeries B | |
OrsoBio | Sep 2024Led | $67 MSeries B | |
Scorpion Therapeutics | Jul 2024Participated | $150 MSeries C | |
Rapalogix Health | Jun 2026Led | $20 MSeries A | |
Cuprum Metals | Jun 2026Participated | $19 MSeries A | |
Skyryse | Feb 2026Participated | $300 MSeries C | |
Mirador Therapeutics | Jan 2026Participated | $250 MSeries B | |
Ursa Major | Nov 2025Participated | $150 MSeries E | |
Egetis Therapeutics | Oct 2025Participated | $19 MOther Equity | |
Equillium | Aug 2025Participated | $30 MOther Equity | |
Caris Life Sciences | Apr 2025Participated | $168 MOther Equity | |
Blue Earth Therapeutics | Oct 2024Participated | $77 MSeries A | |
Formo | Sep 2024Participated | $61 MSeries B | |
OrsoBio | Sep 2024Led | $67 MSeries B | |
Scorpion Therapeutics | Jul 2024Participated | $150 MSeries C |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 1 | 4 |
| Series B | 2 | 11 |
| Series C+ | 0 | 13 |
| Other Equity | 0 | 6 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Aug '20 | 1 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 2 |
| Feb '21 | 1 |
| Mar '21 | 1 |
| Apr '21 | 1 |
| May '21 | 1 |
| Jun '21 | 0 |
| Jul '21 | 3 |
| Aug '21 | 0 |
| Sep '21 | 2 |
| Oct '21 | 2 |
| Nov '21 | 1 |
| Dec '21 | 1 |
| Jan '22 | 1 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 1 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 1 |
| Jun '23 | 0 |
| Jul '23 | 1 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 1 |
| Jan '24 | 1 |
| Feb '24 | 0 |
| Mar '24 | 1 |
| Apr '24 | 2 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 1 |
| Aug '24 | 0 |
| Sep '24 | 2 |
| Oct '24 | 1 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 1 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 1 |
| Sep '25 | 0 |
| Oct '25 | 1 |
| Nov '25 | 1 |
| Dec '25 | 0 |
| Jan '26 | 1 |
| Feb '26 | 1 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 2 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 31 |
| Space & Frontier Tech | 6 |
| Networks, Cloud & Communication | 2 |
| Hardware & Robotics | 1 |
| Government & Defense | 1 |
| Media & Entertainment | 1 |
| Food & Agriculture | 1 |
| AI & Machine Learning | 1 |
| Clean Energy & Sustainability | 1 |
| Gaming & eSports | 1 |
| Transportation & Logistics | 1 |
| Consumer & Lifestyle | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 0 |
| $10M-$25M | 3 |
| $25M-$50M | 2 |
| $50M-$100M | 5 |
| $100M-$250M | 23 |
| $250M-$500M | 4 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 3 of 3 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 31 |
| Europe | 5 |
| Japan | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Invus | 11 |
| Logos Capital | 11 |
| Fidelity Management & Research Company | 9 |
| Casdin Capital | 8 |
| Janus Henderson Investors | 8 |
| Surveyor Capital | 8 |
| T. Rowe Price Associates | 8 |
| OrbiMed | 7 |
| Foresite Capital | 6 |
| Omega Funds | 6 |
| RA Capital Management | 6 |
| TCGX | 6 |
| Alexandria Venture Investments | 5 |
| Boxer Capital | 5 |
| EcoR1 Capital | 5 |
| Perceptive Advisors | 5 |
| Atlas Venture | 4 |
| Catalio Capital Management | 4 |
| Deep Track Capital | 4 |
| Driehaus Capital Management | 4 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 3 | 8% |
| Participating | 34 | 92% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 0 | 0% |
| Co-led | 3 | 100% |
Team
Chief Financial Officer
Chief Operating Officer
Portfolio Manager
Co-founder & Co-Chief Investment Officer